Cardicomm Solutions, Inc. Press Releases

SMART Monitoring Integration of Reka ECG monitoring device to provide access to new US-based and Global ECG Service Markets TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company")today announced that it has completed a HeartCheck™ and SMART Monitoring distribution and co-marketing agreement ("Agreement") with Reka Health, Inc. (REKA), a US based company. REKA will promote sales of the HeartCheck™ PEN through their...

Ammendment to reflect the new release of GEMS™ WIN as a Windows 7 compatible ECG management software upgrade TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has amended its GEMS™software license agreement (“SLA”) with MD Primer Inc. (“MDP”), which was previously described by the Company in its press releases on January 22, 2014, and...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company")today announced that an aggregate of 567,460 incentive stock options have been granted to two directors of the Company and to a contractor of the Company. The 417,460 options issued to the directors are exercisable at $0.18 per share for five years from the date of grant, vest equally over 18 months at the end of each three month period from the date of grant and are subject...

Former Executive of ScottCare, CardioNet and Lifewatch Corporation Set to Drive Sales of GEMS? and Mobile Patient Monitoring Solutions into the U.S. Market TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today announced that Mr. Daniel Pawlik has joined the organization as Vice President, Sales and Marketing for the United States effective January 6, 2014. Mr. Pawlik has held senior executive positions within a number of...

Funding will be used as bridge financing to complete Q1 2014 objectives. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it will be conducting a non-brokered private placement equity financing under which it intends to issue between 4,166,667 to 8,333,334 units at a price of $0.12 per unit for gross proceeds of $500,000 to $1,000,000.  Each unit will be comprised of one...

Free cardiac arrhythmia surveillance available at no cost to those with a physician prescription. Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced it shall be providing HeartCheck™  SMART Monitoring ECG services at no cost effective December 10, 2013 for its USA...

Second CIHR and industry sponsored study to use HeartCheck and SMART Monitoring Technologies. Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced it shall be providing HeartCheckTM  based ECG screening technologies to researchers from the Research Institute of the McGill...

TORONTO, ONTARIO – December 4, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that an aggregate of 700,000 incentive stock options have been granted to certain directors of the Company for services rendered in 2013. The options are exercisable at $0.18 per share for five years from the date of grant, vest...

Raytel Cardiac Services will be the first to launch into the American MCT monitoring market using the CardioComm Solutions Wireless Arrhythmia Services Software Toronto, Canada. – CardioComm Solutions Inc. ( TSX-V:EKG) (“CardioComm Solutions” or the “Company”) confirms the release of a custom GEMSTM Mobile Cardiac Telemetry software (“GEMS M-Air”) solution with web-based device interfacing for use by Raytel Cardiac Services Inc....

Rapid physician ECG interpretation services now available to patients, allied health care workers and physician groups. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) (“CardioComm Solutions” or the “Company”) today confirmed it has released a new version of its GEMS Home software to support the prescription model of the HeartCheck™ ECG Monitor. GEMS Home 1.2 is now available at no cost to new and current owners of both the consumer...

TORONTO, ONTARIO – October 31, 2013, CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 33,626 common shares of the Company in settlement of services provided, as previously described in the Company’s press release dated October 11, 2013. The shares were issued to Mr. Simi...

ZoomerShow Participation Caps Off a Busy Week of Marketing Initiatives to Build Mindshare for the HeartCheck™ PEN Handheld ECG Device TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) will promote consumer awareness of the HeartCheck™ PEN handheld ECG device and offer free ECG readings to visitors this weekend (October 26th to 27th) during the ZoomerShow at the Direct Energy Centre in...

Interest grows as select pharmacies carry the HeartCheck™ PEN for sale in Ontario TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE: EKG) today announced that Remedy’sRx pharmacies have joined the Company’s campaign to promote awareness of the HeartCheck™ PEN. Select pharmacies in more Ontario cities will now be carrying the HeartCheck™ PEN for sale to consumers. ...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) confirms results from the use of the HeartCheck™ ECG Monitor were presented today at Vascular 2013 in Montreal. Researchers from three University of Toronto teaching hospitals and the Centre for Innovation in Complex Care developed the protocol for the national program that screened for Atrial Fibrillation (“AF”) as a risk factor for...

Toronto, Canada – CardioComm Solutions, Inc. ("CardioComm Solutions" or the "Company") (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it intends to issue an aggregate of 33,626 common shares of the Company to Simi Grosman, a director of the Company. The shares will be issued at a deemed price of $0.134 per share, for a total value of $4,500, for services rendered to the Company in the months of July,...

CIHR and industry sponsored study to use HeartCheck™ PEN and ECG monitors to screen 8,000 people through in-pharmacy and primary care physician offices for stroke risk   Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced it is working with the Canadian Atrial...

Select Total Health Pharmacies in Ontario to carry the HeartCheck™ PEN in association with the “Take Control” commercial airing on the CBC television network TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE: EKG) today announced that it has launched a television commercial campaign to promote awareness of the HeartCheck™ PEN and signaling its availability for sale in select...

CEO Interview reviews opportunities in both the consumer and medical ECG services market TORONTO, ONTARIO – CardioComm Solutions, Inc. (CardioComm Solutions) (TSX VENTURE: EKG) confirms that a recent interview with the Wall Street Analyst (WSA) will be featured on the front page of www.thewallstreetanalysts.com for two business days. The interview with Etienne Grima, the Company’s Chief Executive Officer, will be made available to their global investor audience which...

TORONTO, ONTARIO – September 20, 2013, CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 175,979 common shares of the Company in settlement of services provided to CardioComm Solutions by The Lightning Group Ltd. (“TLG”) and LOLA Social Marketing Inc....

 Results from the Heart and Stroke Foundation “Be Pulse Aware” ECG Screening Campaign will be released during Vascular 2013 TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) confirms results from the use of the HeartCheck™ ECG Monitor will be presented at Vascular 2013, a one-time Canadian event of four separate scientific meetings: the Canadian Cardiovascular Congress, the...

 The Zoomer Publication targets population of 15.1 million baby boomers in the Canadian market TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) is pleased to announce that the HeartCheck™ PEN ECG device and SMART Monitoring service were the subject of a special article in the October 2013 issue of Zoomer Magazine, published by ZoomerMedia Limited. Zoomer Magazine is published nine times a...

North America plans will utilize social media strategies including calls to action for arrhythmia screening in sports TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has engaged The Lightning Group (“TLG”) and LOLA Social Marketing (“LOLA”) to provide on-line marketing and social media strategy services. In exchange for these services, CardioComm...

Enhancements include symptom correlation to ECG readings TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirms it has released a new version of its GEMS Home software which is available to both new purchasers of the HeartCheckTM PEN ECG device as well as a free upgrade to current HeartCheckTM PEN owners. CardioComm Solutions has long history of licensing its Global ECG Management System...

Customer advocacy program to provide media promotion of CardioComm Solutions Case Study TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed SunGard Availability Services (Canada) Ltd, a subsidiary of SunGard Data Systems Inc. (“SunGard’), will be promoting CardioComm Solutions in a case study related to the Company’s use of their cloud-based systems infrastructure as...

TORONTO, ONTARIO – August 9, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 250,000 options to the Company’s CEO, Etienne Grima, in accordance with his employment agreement with the Company. The options are exercisable at $0.19 per share for five years from the date of...

Coverage is Geared to Matching Investors with Innovations in Healthcare and Finance Toronto, Canada  – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or “the Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced that it has contracted Crystal Research Associates, LLC (“Crystal Research”), a New York-based independent equity research...